UPDATED Sep 24, 2025
Explore the U.S. (NYSE and NASDAQ) Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
ABBV | US$219.99 | -1.2% | 15.0% | US$393.3b | US$227.22 | PE104.4x | E27.2% | 3.0% | ||
LLY | US$741.85 | -0.7% | -19.8% | US$670.6b | US$884.31 | PE48.3x | E21.3% | 0.8% | ||
AMGN | US$279.22 | -2.6% | -10.8% | US$154.4b | US$311.46 | PE22.7x | E9.5% | 3.4% | ||
DHR | US$185.91 | -2.0% | -30.6% | US$135.8b | US$243.43 | PE39x | E16.4% | 0.7% | ||
BMY | US$44.16 | -1.7% | -11.6% | US$91.4b | US$53.00 | PE17.8x | E6.2% | 5.6% | ||
NTRA | US$163.91 | -5.2% | 32.3% | US$22.5b | US$197.33 | PS11.5x | E67.6% | n/a | ||
INSM | US$141.00 | -3.0% | 93.9% | US$30.7b | US$159.13 | PS74.9x | E64.7% | n/a | ||
GILD | US$113.67 | -0.6% | 38.3% | US$141.9b | US$125.19 | PE22.3x | E12.8% | 2.8% | ||
IQV | US$181.24 | -2.8% | -21.8% | US$31.7b | US$216.42 | PE24.9x | E13.1% | 0% | ||
TEM | US$79.23 | -5.8% | 61.2% | US$14.6b | US$73.45 | PS14.5x | E13.1% | n/a | ||
VRTX | US$376.62 | -0.8% | -18.4% | US$97.4b | US$479.64 | PE26.5x | E13.4% | n/a | ||
ILMN | US$94.41 | -5.0% | -25.2% | US$15.3b | US$111.95 | PE11.5x | E-3.9% | n/a | ||
MRK | US$79.67 | -0.4% | -30.6% | US$199.7b | US$101.60 | PE12.1x | E8.5% | 4.1% | ||
TMO | US$468.00 | -0.4% | -22.0% | US$177.4b | US$546.76 | PE26.8x | E9.5% | 0.4% | ||
CAI | US$30.44 | -5.2% | n/a | US$9.0b | US$39.38 | PS16x | E80.2% | n/a | ||
A | US$124.38 | -1.2% | -10.8% | US$35.7b | US$138.97 | PE28.9x | E10.8% | 0.8% | ||
MENS | US$56.50 | -8.9% | n/a | US$4.8b | n/a | PE-1439.2x | n/a | n/a | ||
ZTS | US$141.67 | -0.7% | -26.0% | US$63.2b | US$190.09 | PE24x | E7.2% | 1.4% | ||
ACAD | US$21.26 | -9.9% | 38.8% | US$4.0b | US$29.63 | PE16.1x | E25.2% | n/a | ||
WAT | US$292.65 | -2.2% | -13.9% | US$17.8b | US$347.14 | PE26.3x | E11.8% | n/a | ||
MDGL | US$426.84 | -3.7% | 97.4% | US$9.9b | US$481.85 | PS18.5x | E66.8% | n/a | ||
HRMY | US$26.76 | -16.6% | -28.2% | US$1.8b | US$48.91 | PE8.5x | E21.4% | n/a | ||
MTD | US$1,242.28 | -1.2% | -12.5% | US$25.9b | US$1,306.36 | PE30.8x | E7.6% | n/a | ||
YDES | US$17.11 | -18.8% | 52.0% | US$1.5b | n/a | PS2357.5x | n/a | n/a |